Non- ionic surfactant vesicles and their therapeutics potentials
DOI:
https://doi.org/10.56511/JIPBS.2016.v3.i02.pp193-201Abstract
Niosomes are a novel drug delivery system in which drug is encapsulated in vesicles. Niosomes are non-ionic surfactant vesicles that have potential applications in the delivery of hydrophilic and hydrophobic drugs. Niosomes proved to be a promising drug carrier and has potential to reduce the side effects of drugs and increased therapeutic effectiveness in various diseases. The success of Niosomes as drug carriers has been reflected in a number of surfactant -based formulations, which are commercially available or are currently undergoing clinical trials. This review is mainly focused on the diseases that have attracted most attention with respect to niosome drug delivery. This vesicular drug delivery system having lots of advantage over other type of drug delivery system. Niosomes and liposomes are equiactive in drug delivery potential and both increase drug Efficacy as compared with that of free drug.
Keywords:
Niosomes, Drug carrier, cancer therapy, Therapeutic applicationDownloads
References
A.J. Baillie, A.T. Florence, R. HumeI, G.T. Murihead, A. Rogerson: The preparation and properties of Niosomes-Nonionic surfactant vesicles. J. Pharm. Pharmacol. 1985; 37:863-868.
Azmin MN, Florence AT, Handjani-Vila RM, Stuart JF, Vanlerberghe G, Whittaker JS: The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice. J Pharm Pharmacol. 1985; 37(4):237-42.
Florence A.T., Cable C., Cassidy J. and Kaye S.B In: Targetting of drugs, Plenum Pres, New York. 1990; 117.
Buckton G and Harwood: Interfacial Phenomena in Drug Delivery and Targeting Academic Publishers, Switzerland. 1995; 154-155.
Stafford S., Baillie A.J and Florence A.T.: Drug effects on the size of chemically defined non-ionic surfactant vesicles. J. Pharm. Pharmacol. 1988; 40: 26.
Couvreur P, Fattal E, Andremont A: Liposomes and Nanoparticles in the treatment of intracellular bacterial infections. Pharm Res. 1991; 8:1079-1086.
Schreier H, Bouwstra J: Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Rel. 1994; 30:1-15.
Hunter CA: Vesicular System (Niosomes and Liposomes) for Delivery of Sodium Stibogluconate in Experimental Murine Visceral Leishmaniasis. J Pharm Pharmacol. 1988; 40(3):161-165.
Malhotra M Jain N K: Niosomes as drug carries, C. B. S Publishers & distributers 1994; 3:81-86.
J.M. Gebicki, M. Hicks: Preparation and properties of vesicles enclosed by fatty acid membranes. Chemistry and Physics of Lipids. 1976; 16(2):142-160.
Okahata Y., Tanamachi S., Nagai M. and Kunitake T. (1981) J. Colloids Interface Sci. 82, 401.36. I.F. Uchegbu, S.P. Vyas, Nonionic surfactant based vesicles, Niosomes in drug delivery pharmaceutics-2 1998; 3370.
Handjani-vila RM. et al: Dispersion of lamellar phases of nonionic lipids in cosmetic products. Int. J. Cosmetic Science, 1979; 1:303-314.
A.I. Blazek-Welsh, D.G. Rhodes: Maltodextrin-based proniosomes. AAPS Pharm. Sci. 2001; 3(1):1-8.
P. Arunothayanun, J.A. Turton, I.F. Uchegbu, A.T. Florence: Preparation and in vitro in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical tubular niosomes. J. Pharm. Sci. 1999; 88:34-38.
I.F. Uchegbu, J.A. Double, J.A. Turton, A.T. Florence: Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monostearate (Span 60) niosomes in the mouse. Pharm. Res. 1995; 12:1019-1024.
T. Yoshioka, B. Sternberg, A.T. Florence: Preparation and Properties of Vesicles (Niosomes) of Sorbitan Monoesters (Span20, Span-40, Span-60 and Span-80) and A Sorbitan Triester (Span-85). Int. J. Pharm. 1994;1-6.
D.D. Lasic: Liposomes: from physics to application Elsevier, Amsterdam, New York, 1993.
Y. Hao, F. Zhao, N. Li, Y. Yang, K. Li: Studies on a high encapsulation of colchicine by a niosome system. Int. J. Pharm. 2002; 73-80.
J.Y. Fang, S.Y. Yu, P.C. Wu, Y.B. Huang, Y.H. Tsai: In vitro skin permeation of estradiol from various proniosome formulations. Int. J. Pharm. 2001; 9199.
M. Manconi, C. Sinico, D. Valenti, G. Loy, A.M.Fadda: Niosomes as carriers for tretinoin. I. preparation and properties. Int. J. Pharm. 2002; 237 – 248.
M. Manconi, D. Valenti, C. Sinico, F. Lai, G. A.M.Fadda: Niosomes as carriers for tretinoin II. Influence of vesicular incorporation on tretinoin photostability. Int. J. Pharm. 2003; 261 – 272.
E. Touitou, H.E. Junginger, N.D. Weiner, T. Nagai, M. Mezei: Liposomes as carriers for topical and transdermal delivery. J. Pharm. Sci. 1994; 83:1189 – 1203.
R. Agarwal, O.P. Katare, S.P. Vyas: Preparation and in vitro evaluation of liposomal/niosomal delivery systems for cantipsoriatic drug dithranol. Int. J. Pharm. 2001; 43 – 52.
J.Y. Fang, C.T. Hong, W.T. Chiu, Y.Y. Wang: Effect of liposomes and niosomes on skin permeation of enoxacin. Int. J. Pharm. 2001; 61 – 72.
N. Udupa, K.S. Chandraprakash, P. Umadevi, G.K. Pillai: Formulation and evaluation of methotrexate niosomes. Drug Develop. Ind. Pharm.1993; 1-8
G. Parthasarathi, N. Udupa, P. Umadevi, G.K. Pillai: Niosome-encapsulated vincristine sulfate: improved anticancer activity with reduced toxicity in mice. J. Drug Targ.1994; 173 – 182.
P. Arunothayanun, J.A. Turton, I.F. Uchegbu, A.T. Florence: Preparation and in vitro in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical tubular niosomes. J. Pharm. Sci. 1999; 34-38.
Y. Hao, F. Zhao, N. Li, Y. Yang, K. Li: Studies on a high encapsulation of colchicine by a niosome system. Int. J. Pharm. 2002; 73-80.
C.P. Jain, S.P. Vyas: Preparation and characterization of niosomes containing rifampicin for lung targeting. J. Microenc. 1995; 401 – 407.
D.M. Williams, K.C. Carter, A. J. Baillie: Visceral leishmaniasis in the BALB/c mouse: a comparison of the in vivo activity of five nonionic surfactant vesicle preparations of sodium stibogluconate. J. Drug Targ. 1995; 1 – 7.
C.O. Rentel, J.A. Bouwstra, B. Naisbett, H.E. Junginger: Niosomes as a novel peroral vaccine delivery system. lnt. J. Pharm. 1999; 161 – 167.
K. Ruckmani, B. Jayakar, S.K. Ghosal: Nonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemias: encapsulation, storage, and in vitro release. Drug Develop Ind. Pharm. 2000; 217 – 222.
D.M. Small, Handbook of lipid research: The physical chemistry of lipids, from alkanes to phospholipids, first ed., Plenum Press, New York, 1986; 14.
I.F. Uchegbu, S.P. Vyas: Non-ionic surfactant based vesicles Niosomes in drug delivery pharmaceutics 1998; 2:33-70.
Biju S. S., Talegaonkar S., Mishara P. R., Khar R. K.: Vesicular systems: An overview. Indian J. Pharm. Sci. 2010; 141 — 151.
Azmin MN. et al.: The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice. J Pharm. Pharmacol. 1985; 37: 237-242.
Chandraprakash K.S., Udupa N., umadevi P. and Pillai G.K.: Pharmacokinetic evaluation of surfactatant vesicles containing methotrexate in tumor bearing mice. Int. J. Pharma 1990; R1-R3:61
Cable C. An examination of the effects of Surface Modifications on the Physicochemical and Biological Properties of Non-ionic Surfactant Vesicles [PhD thesis]. Glasgow: University of Strathclyde. 1989.
Uchegbu IF1, Double JA, Turton JA, Florence AT: Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monostearate (Span 60) Niosomes in the mouse. Pharm Res. 1995;12(7):1019-24
Raja Naresh R A, Udupa N: Antiinflammatory activity of niosome encapsulated diclofenac sodium in arthritis rats. International journal of pharmaceutics 1994; 26(1):46-48.
Parthasarathi G. et al: Formulation and invitro evaluation of vincristine encapsulated niosomes. Ind. J. pharma Sci. 1994; 56:90.
Zhang JQ. et al: Studies on lung targeted niosomes of carboplatin. European J. Pharm. Sci. 2001; 36:303.
Naresh RAR. Et al: Kinetics and tissue distribution of niosomal bleomycin in tumor bearing mice. Ind. J. Pharm. Sci. 1996; 58:230.
Yoshida H., Lehr C.M., Kok W., Junginger H.E. and Verhof J.C.: Niosomes for oral delivery of peptide drugs. J.contr. Rel. 1992; 21:145.
Varshosaz J.et al: Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug delivery 2003;10:251.
C.A. Hunter, T.F. Dolan, G.H. Coombs, A.J. Baillie: Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis. J. Pharm. Pharmacol. 1988; 40(3):161-165.
A.J. Baillie, G.H. Coombs, T.F. Dolan: Nonionic surfactant vesicles (niosomes) as delivery system for the antileishmanial drug, sodium stilbogluconate. J. Pharm. Pharmacol.1986; 502-505.
Hunter CA1, Dolan TF, Coombs GH, Baillie AJ: Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis. J Pharm Pharmacol, 1988;161-165.
Baillie AJ, Coombs GH, Dolan TF, Laurie J: Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate. J Pharm Pharmacol.1986; 38(7):502-505.
Jayaraman CS, Ramachandran C and Weiner N: Topical delivery of erythromycin from various formulations: an in vivo hairless mouse study. J. Pharm. Sci. 1996; 85(10):1082-1084.
J.M. Brewer, J.A. Alexander: The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin. Immunology 1992; 75(4):570-575.
Moser P., Marchand A.M., Labrude P., Handjanivila R.M. and Vigneron C: Hemoglobin Niosomes Preparation, functional and physico-chemical properties, and stability. Pharmaceutica Acta Helvetiae 1989; 164(7):192-202.
Korkaz M., Ozer A.Y. and Hincal A.A: In: synthetic surfactant vesicles, niosomes and other non-phopholipid vesicular system, Uchegbu I.F.(Ed.) Hard wood Academic Press, Netherland 2000; 83.
Desai T. R, Finlay WH: Nebulization of niosomal all trans-retinoic acid, an inexpensive alternative to conventional liposome. Int J. Pharm 2002; 241(2):31117.
Luciani A. et al: Glucose receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes. J. Radiology 2004; 231:135.
Schreier. H, Bouwstra. J: Liposome & niosome as topical drug carrier. Journal of controlled release1994; 30:1-15.
Shahiwala A and Misra A: Studies in topical application of niosomally entrapped nimesulide. J. Pharma. Sci, 2002; 5:220.
Reddy DN and Udupa N: Formulation and evaluation of oral and transdermal preparation of flurbiprofen and piroxicam incorporated with different carriers. Drug Dev. Ind. Pharm 1993; 843.
Brewer JM and Alexander JA: The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin. Immunology 1992; 75(4):570-575.
Jayaraman CS, Ramachandran C and Weiner N: Topical Delivery of Erythromycin from Various Formulations an In Vivo Hairless Mouse Study. J Pharm Sci.1996; 85(10):1082-1084.
Dowton S.M. Z. Hu, C, Ramachandran, D.F.H Wallach and N. Weiner: Influence of liposomal composition on topical delivery of encapsulated cyclosporine: An vitro study using hairless mouse skin. STP Pharma sciences 1993; 404.
S.M. Niemiec, latta JM; Ramachandran C; Weiner ND; Roessler BJ: Perifollicular transgenic expression of human interleukin-1 receptor antagonist protein following topical application of novel liposome-plasmid DNA formulations invivo. Journal of pharmaceutical sciences 1997; 86(6):701-708 .
S. Chauhan, M.J. Luorence: The preparation of polyoxyethylene containing non-ionic surfactant vesicles. J. Pharm. Pharmacol1989; 41.
C.A. Hunter, T.F. Dolan, G.H. Coombs, A.J. Baillie: Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis. J. Pharm. Pharmacol. 1988; 40(3):161-163.
Published
How to Cite
Issue
Section
Copyright (c) 2016 Naresh Kalra, G. Jeyabalan, Gurpreet Singh, Suresh Choudhary
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at